A61P 19 - Drugs for skeletal disorders

Patents for A61P 19 - Drugs for skeletal disorders (81,981)
11/2002
11/07/2002	US20020164349 Induction apoptosis; west nile virus therapy
11/07/2002	US20020164323 Antithrombin; antiinflammatory agents, rheumatic diseases
11/07/2002	CA2446514A1 Fused pyrimidines as antagonists of the corticotropin releasing factor (crf)
11/07/2002	CA2446079A1 Modulators of elastase inhibitor secretion
11/07/2002	CA2446064A1 Nitrosated and nitrosylated nebivolol and its metabolites, compositions and methods of use
11/07/2002	CA2445847A1 A molecular marker
11/07/2002	CA2445839A1 Anti-inflammatory 17.beta.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.alpha
11/07/2002	CA2445826A1 Treatment and diagnosis of macrophage mediated disease
11/07/2002	CA2445763A1 Compositions comprising an anti-microtubule agent and a polypeptide or a polysaccharide and the use thereof for the preparation of a medicament for the treatment of inflammatory conditions
11/07/2002	CA2445702A1 Control of compactability through crystallization
11/07/2002	CA2445629A1 Substituted benzofurans and benzothiophenes, methods of making and methods of use as integrin antagonists
11/07/2002	CA2445568A1 Triazole-derived kinase inhibitors and uses thereof
11/07/2002	CA2445376A1 Substance rkb-3564 having angiogenesis inhibitory action
11/07/2002	CA2445357A1 Pyrazole derived kinase inhibitors
11/07/2002	CA2445348A1 Novel benzylpiperidine compound
11/07/2002	CA2445343A1 Use of protein and essential amino acids to treat amenorrhea and related disorders
11/07/2002	CA2445338A1 G-protein coupled receptors
11/07/2002	CA2445298A1 Use of agt and its derivatives for manufacturing anti-angiogenesis pharmaceutical compositions
11/07/2002	CA2445290A1 A pharmaceutical tablet having a high api content
11/07/2002	CA2444911A1 Fusion molecules and methods for treatment of immune diseases
11/07/2002	CA2444500A1 Triazole compounds useful in treating diseases associated with unwanted cytokine activity
11/07/2002	CA2444499A1 Triazole compounds useful in treating diseases associated with unwanted cytokine activity
11/07/2002	CA2444436A1 Dual inhibitors of pde 7 and pde 4
11/07/2002	CA2443835A1 Fused heterocyclic inhibitors of phosphodiesterase (pde) 7
11/07/2002	CA2443625A1 Use of bisphosphonates in the treatment of bone metastasis associated with prostate cancer
11/07/2002	CA2443381A1 Use of azithromycin for the manufacture of a medicament for treatment of non-infective inflammatory diseases
11/07/2002	CA2440775A1 The nk1 fragment of hepatocyte growth factor/scatter factor (hgf/sf) and variants thereof, and their use
11/07/2002	CA2429001A1 Cysteine protease inhibitors
11/07/2002	CA2408369A1 Substituted indoles as parp inhibitors
11/06/2002	EP1255112A2 Treatment of T-cell mediated diseases
11/06/2002	EP1255110A2 Methods and products for identifying modulators of P2X7 receptor activity, and their use in the treatment of skeletal disorders
11/06/2002	EP1254898A1 Benzene-fused heterocycle derivatives and drugs containing the same as the active ingredient
11/06/2002	EP1254667A1 Drug comprising combination
11/06/2002	EP1254270A1 Methods and materials relating to cub domain polypeptides and polynucleotides
11/06/2002	EP1254268A1 Methods and materials relating to leucine-rich repeat protein-like (lrr protein-like) polypeptides and polynucleotides
11/06/2002	EP1254266A1 Methods and materials relating to alpha-2-macroglobulin-like polypeptides and polynucleotides
11/06/2002	EP1254237A2 Aggregate-free urate oxidase for preparation of non-immunogenic polymer conjugates
11/06/2002	EP1254235A2 Drug metabolizing enzymes
11/06/2002	EP1254224A2 Interferon-alpha induced genes
11/06/2002	EP1254212A2 Methods of preparing and using a viral vector library
11/06/2002	EP1254174A2 Human cyr61
11/06/2002	EP1254138A1 Pyridine derivatives inhibiting angiogenesis and/or vegf receptor tyrosine kinase
11/06/2002	EP1254134A2 1,3-dihydro-2h-indol-2-one derivatives,and their use as ligands for v1b or v1b and v1a arginine-vasopressin-receptors
11/06/2002	EP1254133A2 Indol-3-yl derivatives
11/06/2002	EP1254132A1 Food product and process
11/06/2002	EP1254130A1 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof
11/06/2002	EP1254124A1 Dipeptide nitrile cathpsin k inhibitors
11/06/2002	EP1254123A1 2-benzothiazolyl urea derivatives and their use as protein kinase inhibitors
11/06/2002	EP1254119A1 Pyrimidine derivatives as selective inhibitors of cox-2
11/06/2002	EP1254118A2 Substituted 1,2,3,4- tetrahydroquinoline-2-carboxylic acid derivatives
11/06/2002	EP1254116A1 Alpha v integrin receptor antagonists
11/06/2002	EP1254111A1 Novel vitamin d analogues
11/06/2002	EP1254106A1 Calcilytic compounds
11/06/2002	EP1253966A2 Substances and agents for positively influencing collagen
11/06/2002	EP1253928A2 Novel haptotactic peptides
11/06/2002	EP1253923A1 Pharmaceutical compositions containing anti-beta 1 integrin compounds and uses
11/06/2002	EP1253922A2 Statin-type bone growth stimulators
11/06/2002	EP1157024B1 Acetylenic ortho-sulfonamido and phosphinic acid amido bicyclic heteroaryl hydroxamic acids as tace inhibitors
11/06/2002	EP1097159B1 Phosphinous and phosphonic acid derivatives used as medicaments
11/06/2002	EP1012137B1 Aromatic c16-c20-substituted tetrahydro prostaglandins useful as fp agonists
11/06/2002	EP0901373B1 Alpha v Beta 3 ANTAGONISTS
11/06/2002	CN1378544A Substituted azoles compounds
11/06/2002	CN1378543A Substituted pyridazines and fused pyridazines with angiogenesis inhibiting activity
11/06/2002	CN1378541A Inhibitors of c-JUN N-terminal kinase (JNK) and other protein kinases
11/06/2002	CN1378537A 嘧啶衍生物 Pyrimidine derivatives
11/06/2002	CN1378535A 四氢喹啉衍生物 Tetrahydroquinoline derivative
11/06/2002	CN1378528A Use of carbonylamino derivatives against CNS disorders
11/06/2002	CN1378459A Treatment of auto immune diseases with antagonists which bind to B cell surface markers
11/06/2002	CN1378457A Methods and compositions useful for modulation of angiogenesis using protein kinase Raf and Ras
11/06/2002	CN1378455A Use of diterpenoid triepoxides as anti-proliferative agent
11/06/2002	CN1378454A Aminoalkylenephosphonates for treatment of bone disorders
11/06/2002	CN1377695A Traditional Chinese herbal medicine preparation for curing hyperosteogeny
11/06/2002	CN1377693A Traditional Chinese medicine wine fore relaxing muscles and tendons and activating blood circulation, expelling wind and stopping pain, and relieving flatulence and relaxing the bowels
11/06/2002	CN1377684A Medicinal formula for curing hyperosteogeny
11/06/2002	CN1377683A Medicinal formula for curing sciatic nerve disease and protrusion of lumbar intervertebral disc
11/06/2002	CN1377682A Bone-setting pain stopping paste
11/06/2002	CN1377669A Recovering medicine for lumbar vertebra
11/06/2002	CN1377657A Muscloe relaxing and fracture setting paste
11/05/2002	US6476214 Inhibition of cytokine production
11/05/2002	US6476195 Secreted protein HNFGF20
11/05/2002	US6476079 Devices for the delivery of drugs having antiprogestinic properties
11/05/2002	US6476077 N-(2-phenyl-4-amino-butyl)-1-naphthamides as neurokinin-1 receptor antagonists
11/05/2002	US6476052 Isoindolines, method of use, and pharmaceutical compositions
11/05/2002	US6476031 Quinazoline derivatives as medicaments
11/05/2002	US6476026 Compounds and compositions as protease inhibitors
11/05/2002	US6476025 Phenylphennanthridines with PDE-IV inhibiting activity
11/05/2002	US6476023 Aromatic heterocyclic compounds as anti-inflammatory agents
11/05/2002	US6476020 Imidazo-benzazepine compounds, their compositions and uses
11/05/2002	US6476010 Orally administering to a post-menopausal woman a fat soluble vitamin and a fat soluble vitamin absorption increasing effective amount of l-carnitine or salts
11/05/2002	US6476006 Compact form for oral administering; bone disorders
11/05/2002	US6475986 Uses of THANK, a TNF homologue that activates apoptosis
11/05/2002	US6475766 Human osteoclast-derived cathepsin
11/05/2002	US6475532 Calcium channel antagonist possessing an inhibitory action against secretion of parathyroid hormones and a use thereof
11/05/2002	US6475528 Preparation for regenerating collagen
11/05/2002	US6475490 Compositions and methods for promoting tissue repair using heat shock proteins
11/05/2002	US6475487 Treatment of a patient by administering an antibody that inhibits cathepsin O
11/04/2002	WO2004001058A2 Transcription factor modulating compounds and methods of use thereof
10/2002
10/31/2002	WO2002086156A2 New polynucleotides and polypeptides of the ifn$g(a)-17 gene
10/31/2002	WO2002086113A2 Enzyme and snp marker for disease
10/31/2002	WO2002086104A1 Progenitor cell populations, expansion thereof, and growth of non-hematopoietic cell types and tissues therefrom

1 ... 624 625 626 627 628 629 630 631 632 633 634 635 636 637 638 639 640 641 642 643 644 ... 820